Arcoxia: Targeted Relief for Chronic Inflammatory Pain

Arcoxia

Arcoxia

Arcoxia is used to treat acute and chronic signs and symptoms of osteoarthritis and rheumatoid arthritis, acute gouty arthritis. It relieves acute pain and chronic musculoskeletal pain. It is also used in management of ankylosing spondylitis.
Product dosage: 120mg
Package (num)Per pillPriceBuy
301.64 $49.14 $ (0%)🛒 Add to cart
601.23 $98.28 $ 73.71 $ (25%)🛒 Add to cart
901.08 $147.42 $ 97.11 $ (34%)🛒 Add to cart
1201.02 $196.56 $ 122.85 $ (38%)🛒 Add to cart
1800.95 $294.84 $ 170.82 $ (42%)🛒 Add to cart
2700.91 $442.26 $ 244.53 $ (45%)🛒 Add to cart
360
0.88 $ Best per pill
589.68 $ 317.07 $ (46%)🛒 Add to cart
Product dosage: 60mg
Package (num)Per pillPriceBuy
601.01 $60.84 $ 60.84 $ (0%)🛒 Add to cart
900.91 $91.26 $ 81.90 $ (10%)🛒 Add to cart
1200.85 $121.68 $ 101.79 $ (16%)🛒 Add to cart
1800.80 $182.52 $ 143.91 $ (21%)🛒 Add to cart
2700.77 $273.78 $ 207.09 $ (24%)🛒 Add to cart
360
0.75 $ Best per pill
365.04 $ 271.44 $ (26%)🛒 Add to cart
Product dosage: 90mg
Package (num)Per pillPriceBuy
601.09 $65.52 $ (0%)🛒 Add to cart
900.97 $98.28 $ 87.75 $ (11%)🛒 Add to cart
1200.92 $131.04 $ 109.98 $ (16%)🛒 Add to cart
1800.85 $196.56 $ 153.27 $ (22%)🛒 Add to cart
2700.81 $294.84 $ 219.96 $ (25%)🛒 Add to cart
360
0.79 $ Best per pill
393.12 $ 285.48 $ (27%)🛒 Add to cart
Synonyms

Arcoxia (etoricoxib) is a prescription nonsteroidal anti-inflammatory drug (NSAID) belonging to the class of selective COX-2 inhibitors. It is specifically engineered to provide potent anti-inflammatory, analgesic, and antipyretic effects while minimizing the gastrointestinal complications often associated with traditional NSAIDs. This medication is indicated for the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis. Its mechanism of action involves selective inhibition of cyclooxygenase-2 (COX-2), an enzyme responsible for inflammation and pain, thereby offering a refined approach to managing chronic musculoskeletal conditions under appropriate medical supervision.

Features

  • Active ingredient: Etoricoxib
  • Drug class: Selective COX-2 inhibitor
  • Available in tablet formulations: 60 mg, 90 mg, 120 mg
  • Prescription-only medication
  • Once-daily dosing regimen for most indications
  • Not indicated for use in pediatric populations
  • Manufactured under stringent pharmaceutical quality controls

Benefits

  • Provides effective and sustained relief from inflammatory pain and stiffness associated with chronic arthritic conditions.
  • Reduces the risk of gastrointestinal ulcers and bleeding compared to non-selective NSAIDs due to its COX-2 selectivity.
  • Offers convenient once-daily dosing, improving patient adherence to long-term treatment regimens.
  • Demonstrates significant improvement in physical function and quality of life measures in patients with osteoarthritis and rheumatoid arthritis.
  • Effectively manages acute pain flares in gouty arthritis with rapid onset of action.
  • Maintains anti-inflammatory efficacy comparable to traditional NSAIDs with a potentially improved safety profile for the GI tract.

Common use

Arcoxia is commonly prescribed for the management of chronic inflammatory conditions including osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It is also indicated for the treatment of acute gouty arthritis attacks. Healthcare providers may consider Arcoxia particularly for patients who require NSAID therapy but are at increased risk of gastrointestinal complications. The medication is typically used as part of a comprehensive treatment plan that may include physical therapy, lifestyle modifications, and other pharmacological interventions tailored to the individual patient’s condition and response to therapy.

Dosage and direction

The recommended dosage of Arcoxia varies depending on the condition being treated:

  • Osteoarthritis: 30 mg once daily, may be increased to 60 mg once daily if needed
  • Rheumatoid arthritis: 60 mg once daily, may be increased to 90 mg once daily if needed
  • Ankylosing spondylitis: 90 mg once daily
  • Acute gouty arthritis: 120 mg once daily for maximum 8 days

Tablets should be taken orally with or without food, at approximately the same time each day. The lowest effective dose should be used for the shortest duration possible to control symptoms. Dosage adjustment is recommended for patients with hepatic impairment or those taking certain concomitant medications. Elderly patients generally do not require dosage adjustment unless they have compromised renal or hepatic function.

Precautions

Patients should be carefully evaluated before initiating Arcoxia therapy, particularly those with a history of cardiovascular disease, hypertension, heart failure, or established ischemic heart disease. Regular monitoring of blood pressure is recommended during treatment. Caution is advised in patients with pre-existing renal or hepatic impairment, dehydration, or hypovolemia. Patients should be advised to report any signs of gastrointestinal bleeding, skin reactions, or edema. Arcoxia may mask fever and inflammation, potentially obscuring the signs of infection. Use with caution in patients with a history of asthma, as NSAIDs may exacerbate bronchospasm.

Contraindications

Arcoxia is contraindicated in patients with:

  • Known hypersensitivity to etoricoxib or any components of the formulation
  • Active peptic ulceration or gastrointestinal bleeding
  • Severe hepatic dysfunction (Child-Pugh score ≥9)
  • Estimated creatinine clearance <30 mL/min
  • Inflammatory bowel disease
  • Congestive heart failure (NYHA Class II-IV)
  • Established ischemic heart disease, peripheral arterial disease, or cerebrovascular disease
  • Hypertension uncontrolled by medication
  • Third trimester of pregnancy and during lactation
  • Children and adolescents under 16 years of age

Possible side effect

Common side effects (≥1/100 to <1/10):

  • Headache, dizziness
  • Hypertension
  • Edema, fluid retention
  • Dyspepsia, abdominal pain
  • Increased liver enzymes

Uncommon side effects (≥1/1,000 to <1/100):

  • Palpitations, tachycardia
  • Gastritis, gastroesophageal reflux disease
  • Stomatitis, mouth ulcers
  • Fatigue, insomnia
  • Pruritus, rash

Rare side effects (≥1/10,000 to <1/1,000):

  • Angioedema, urticaria
  • Confusion, hallucinations
  • Hepatitis, jaundice
  • Acute renal failure
  • Stevens-Johnson syndrome

Drug interaction

Arcoxia may interact with several medications including:

  • Warfarin and other anticoagulants (increased risk of bleeding)
  • Lithium (increased lithium levels)
  • Methotrexate (increased methotrexate toxicity)
  • Diuretics and ACE inhibitors (reduced antihypertensive effect)
  • Cyclosporine and tacrolimus (increased nephrotoxicity)
  • Other NSAIDs including aspirin (increased GI toxicity)
  • SSRIs and SNRIs (increased risk of gastrointestinal bleeding)
  • Rifampicin (reduced etoricoxib concentrations)

Missed dose

If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. Patients should be advised to maintain a consistent dosing routine and consider using reminder systems to ensure regular administration.

Overdose

Symptoms of overdose may include lethargy, drowsiness, nausea, vomiting, epigastric pain, gastrointestinal bleeding, hypertension, acute renal failure, and respiratory depression. There is no specific antidote for etoricoxib overdose. Management should include supportive and symptomatic treatment with gastric lavage and activated charcoal if presented within 4 hours of ingestion. Hemodialysis is not effective due to high protein binding. Monitor and support vital functions, particularly renal function and electrolyte balance.

Storage

Store at room temperature (15-30°C or 59-86°F) in the original container to protect from moisture and light. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Do not transfer tablets to other containers as this may affect stability. Properly dispose of any unused or expired medication according to local regulations, preferably through medication take-back programs.

Disclaimer

This information is provided for educational purposes only and does not constitute medical advice. Arcoxia is a prescription medication that should only be used under the supervision of a qualified healthcare professional. The prescribing physician should consider the individual patient’s medical history, current medications, and risk factors before initiating therapy. Patients should not adjust their dosage or discontinue treatment without consulting their healthcare provider. Always follow the prescribed dosage and report any adverse effects promptly.

Reviews

Clinical studies have demonstrated Arcoxia’s efficacy in managing chronic inflammatory conditions with a favorable gastrointestinal safety profile compared to traditional NSAIDs. In a meta-analysis of randomized controlled trials involving over 34,000 patients, etoricoxib showed significant improvement in pain scores and physical function across various arthritic conditions. Many rheumatologists report positive patient experiences with improved quality of life and reduced gastrointestinal adverse events. However, some clinicians express caution regarding cardiovascular risk factors and emphasize the importance of proper patient selection and monitoring. Long-term observational studies continue to provide data on real-world effectiveness and safety profiles.